Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 86 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 8349899

    Selective inhibitors of EG5 motors and methods of use

    Arrowhead Center, Inc. · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted
  2. US 8349838

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted
  3. US 8344153

    Inhibitors of phosphatidylinositol 3-kinase

    Vertex Pharmaceuticals Incorporated · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  4. US 8343998

    Triazolothiadiazole inhibitor of c-Met protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  5. US 8343952

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  6. US 8338461

    1-heterocyclylsulfonyl, 3-aminomethyl, 5-(hetero-)aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  7. US 8338412

    Inhibitors of P38

    Vertex Pharmaceuticals Incorporated · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  8. US 8338462

    1-heterocyclylsulfonyl, 3-aminomethyl, 5- (hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  9. US 8338597

    Pyridones useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  10. US 8329662

    Prodrug of an ICE inhibitor

    Vertex Pharmaceuticals Incorporated · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  11. US 8329745

    Small molecule inhibitors of ghrelin O-acyltransferase

    The Board of Regents of the University of Texas System · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  12. US 8329900

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  13. US 8323671

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  14. US 8324258

    F1F0-ATPase inhibitors and related methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  15. US 8324155

    Quinoxaline-containing compounds as hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  16. US 8324385

    Diacylglycerol acyltransferase inhibitors

    Madrigal Pharmaceuticals, Inc. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  17. US 8318727

    Polo-like kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted
  18. US 8318945

    Metalloprotein inhibitors

    The Regents of the University of California · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted
  19. US 8318939

    Kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted
  20. US 8318467

    Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes

    Vertex Pharmaceuticals Incorporated · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted
  21. US 8314141

    Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

    Vertex Pharmaceuticals Incorporated · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted
  22. US 8309566

    Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

    Rigel Pharmaceuticals, Inc. · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  23. US 8309543

    Compositions useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  24. US 8304414

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted